Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39045

DNAH5 Knockout HT29 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

The DNAH5 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population in HT29 human colorectal adenocarcinoma cells, designed to disrupt DNAH5 gene expression. This loss-of-function model targets the outer dynein arm heavy chain DNAH5, a core motor protein essential for ciliary beat generation, which is transcriptionally regulated by FOXJ1 and functions in complexes with DNAI1 and other axonemal dynein factors. The HT29 intestinal epithelial background supports studies on mucociliary clearance and ciliary biology. Key applications include investigating ciliary motility, modeling primary ciliary dyskinesia, screening ciliopathy therapeutics, and performing mucociliary clearance and barrier integrity assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HT29

    Gene Name

    DNAH5

    Gene Identifier

    NCBI Gene ID 1767

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    McCoy's 5A

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAH5 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the HT29 human colorectal adenocarcinoma cell line. This loss-of-function model disrupts DNAH5, abrogating functional protein expression for investigations into its role in epithelial cell biology. The polyclonal format offers a heterogeneous cell pool, enabling robust, population-level analysis of DNAH5-dependent phenotypes without single-cell clone bias. It is optimized for reproducible experiments in ciliary biology and disease modeling.

HT29 cells, isolated from a primary tumor in a 44-year-old female, serve as a classical intestinal epithelial model with both enterocytic and mucin-secreting capabilities. These cells readily form polarized monolayers with tight junctions and apical secretion, making them ideal for studying barrier integrity, mucin production, and epithelial transport. Under differentiation conditions, HT29 cells can express motile cilia-associated factors, allowing the study of mucociliary clearance mechanisms in an intestinal context.

DNAH5 encodes a heavy chain of outer dynein arms, motor complexes that hydrolyze ATP to drive ciliary bending. Its expression is transcriptionally regulated by FOXJ1 and RFX factors, key drivers of multiciliogenesis downstream of Notch inhibition and E2F4. DNAH5 forms complexes with axonemal dynein components including DNAI1, DNAI2, DNAL1, CCDC114, and CCDC151, which are essential for dynein assembly and ciliary motility. Knockout of DNAH5 leads to reduced ciliary beat frequency, impaired mucociliary transport, and compromised epithelial defense against pathogens.

In the HT29 intestinal epithelial backdrop, DNAH5 knockout provides a platform to examine ciliary motor function in a cell type capable of mucin secretion and ciliated differentiation. This model is particularly relevant for primary ciliary dyskinesia research, as it allows dissection of DNAH5??s role in luminal clearance and surface liquid homeostasis beyond the respiratory tract. It facilitates comparative studies of ciliopathy phenotypes in gastrointestinal epithelia, which are often overlooked but may contribute to disease manifestations.

Researchers can employ high-speed video microscopy for ciliary beat frequency analysis, immunofluorescence for dynein complex localization, and mucociliary clearance assays to quantify transport function. Complementary techniques such as Western blotting, RT-qPCR, and RNA sequencing enable validation of knockout and transcriptomic profiling. These cells are also suited for therapeutic screening and genetic rescue experiments targeting dynein motor deficits. For additional technical information or assistance, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)